Skip to content

Virtual Reality Experiences for Anxiety and Pain Control

Impact of Different Virtual Reality Experiences on Anxiety and Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04759183
Enrollment
32
Registered
2021-02-18
Start date
2021-03-05
Completion date
2022-08-25
Last updated
2022-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

Brief summary

This trial studies the impact of virtual reality experiences on anxiety before surgery and pain after surgery. The goal of this study is to examine how different virtual reality experiences may help reduce anxiety and improve pain control, which may help reduce the need for medications such as opioids.

Detailed description

PRIMARY OBJECTIVE: I. To measure the impact of a gaming virtual reality (VR) experience compared to a mindfulness VR experience on preoperative anxiety and postoperative pain. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients participate in a VR intervention (Angry Birds) over 15 minutes before standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes after surgery. ARM II: Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after surgery.

Interventions

Participate in VR Game Angry Birds

Participate in VR Meditation TRIPP

OTHERSurvey Administration

Ancillary studies

Sponsors

Oregon Health and Science University
CollaboratorOTHER
OHSU Knight Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults (18 years or older and younger than 89) * Able to consent * English-speaking

Exclusion criteria

* Non-English speaking patients because the VR content is only available in English * Have symptoms concerning for an active respiratory infection or are on contact or isolation precautions * Any active eye discharge * A history of seizure, epilepsy, or hypersensitivity to flashing light * Have a history of motion sickness or vertigo * Have active nausea or vomiting * Psychiatric conditions that may interfere with the ability to successfully participate in the study * Have cardiac pacemakers * Require hearing aids at all times that cannot be removed * Have defibrillators * Have wound dressings on the head or neck that prevent comfortable use of the VR headset

Design outcomes

Primary

MeasureTime frameDescription
Change in preoperative anxiety scoresBaseline up to pre surgery (estimated 1 day)Assessed by visual analogue scale (VAS) from 0-100mm.
Change in postoperative pain scoresBaseline after surgery up to study completion (estimated 1 day)Assessed by VAS scale from 0-100mm.

Secondary

MeasureTime frameDescription
Change in blood pressureimmediately before intervention, and then immediately after intervention (estimated 1 day)mmHg
Patient enjoyment of each VR experienceUp to study completion (estimated 1 day)Likert scale (1-5). 1 represents the lowest score, and 5 represents the highest.
Change in heart rateimmediately before intervention, and then immediately after intervention (estimated 1 day)beats per minute (bpm)
Patient desire to use VR more in their healthcareUp to study completion (estimated 1 day)Likert scale (1-5). 1 represents the lowest score, and 5 represents the highest.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026